Nurix logo

Nurix

About

Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Nurix is focused on developing drugs to treat cancer including the novel, small molecule immuno-oncology agents.

Photos

Add photos to showcase Nurix’s culture

Values

Add Nurix’s values

Insider experiences

Share your experience of working at Nurix

Arthur T. Sands
President, CEO & Board Director
Collapse
Gwenn M. Hansen
Chief Scientific Officer
Stefani A. Wolff
COO & EVP, Product Development
Michael T. Lotze
Chief Cellular Therapy Officer
Christine Ring
General Counsel & Secretary
Jason Kantor
EVP, Finance & Business Strategy
Robert J. Brown
EVP, Head of Clinical Development
Cristiana Guiducci
SVP, Immunology & Oncology Research
Michael Mischke-Reeds
SVP, Strategy & Portfolio
Christopher B. Phelps
VP & Head of Early Discovery
Kim Trahan
VP & Head of Program & Portfolio Management
Janine Powers
VP & Head of Translational Medicine
Seema P. Rogers
VP & Head of Clinical Operations
Ena Wang
VP, Cell Therapy & Product Development
Raf Lambrecht
VP, Head of Regulatory
Bev Benson
VP, Head of Clinical Science
Eric Schlezinger
Chief People Officer
Jen Dolan
Vice President, Market Strategy, BTK Franchise Team Leader

Add your teams to show how people work together at Nurix

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure